TOPOTECAN, TOPOTECAN, IRINOTECAN, TOPOTECAN, lurbinectedin, TOPOTECAN
PM1183-C-008-21
Phase 3 small_molecule active
Quick answer
TOPOTECAN, TOPOTECAN, IRINOTECAN, TOPOTECAN, lurbinectedin, TOPOTECAN for Small Cell Lung Cancer (SCLC) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Small Cell Lung Cancer (SCLC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active